Literature DB >> 8132769

Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

P Langlade-Demoyen1, N Ngo-Giang-Huong, F Ferchal, E Oksenhendler.   

Abstract

We report on the detection of HIV-specific cytotoxic T lymphocytes (CTL) among 23 regular partners of HIV-infected individuals. 15 of the 46 individuals enrolled in the study were positive for HLA-A2.1 typing. Among the 23 contacts studied, 7 were seropositive and 16 were seronegative on repeated tests. None of the 16 seronegative contacts were positive for p24 antigenemia nor were they positive by the lymphocytes coculture assay, although, in two instances HIV-1 DNA could be detected by PCR (in one case using a gag SK 38/39 primer, and in the other using a primer for the pol P3/P4 primer). These two individuals remained seronegative for 18 and 36 mo, respectively. HIV-specific cytotoxicity was performed in the 15 HLA-A2.1 subjects (7 indexes, 2 seropositive contacts, and 6 seronegative contacts) and in 4 HLA-matched HIV negative donors. CTL specific for env, gag, or nef proteins could not be detected in unstimulated bulk cultures of peripheral blood lymphocytes in any of the six seronegative contacts. However, using a limiting dilution assay we found an usually high frequency of HIV nef-specific CTL precursors (CTLp) for HIV env and gag was very similar to that observed in seronegative HLA-matched healthy donors. Because no presence of HIV could be demonstrated in these individuals, these findings argue against the possibility of a silent HIV infection and suggest that a CTL response against nef may be involved in a rapid and effective clearance of the virus after sexual exposure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132769      PMCID: PMC294083          DOI: 10.1172/JCI117085

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Polymerase chain reaction testing of HIV-1 seronegative at-risk individuals.

Authors:  J J Lefrere; M Mariotti; A M Courouce; P Rouger; C Salmon; D Vittecoq
Journal:  Lancet       Date:  1990-06-09       Impact factor: 79.321

2.  Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain.

Authors:  V Soriano; I Hewlett; J Tor; B Clotet; J Epstein; M Foz
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

3.  Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction.

Authors:  F Laure; V Courgnaud; C Rouzioux; S Blanche; F Veber; M Burgard; C Jacomet; C Griscelli; C Brechot
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

4.  HIV revealed: toward a natural history of the infection.

Authors:  D Baltimore; M B Feinberg
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

5.  Duration of human immunodeficiency virus infection before detection of antibody.

Authors:  C R Horsburgh; C Y Ou; J Jason; S D Holmberg; I M Longini; C Schable; K H Mayer; A R Lifson; G Schochetman; J W Ward
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

6.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

7.  Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.

Authors:  N Chenciner; F Michel; G Dadaglio; P Langlade-Demoyen; A Hoffenbach; A Leroux; F Garcia-Pons; G Rautmann; B Guy; J M Guillon
Journal:  Eur J Immunol       Date:  1989-09       Impact factor: 5.532

8.  Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men.

Authors:  S M Wolinsky; C R Rinaldo; S Kwok; J J Sninsky; P Gupta; D Imagawa; H Farzadegan; L P Jacobson; K S Grovit; M H Lee
Journal:  Ann Intern Med       Date:  1989-12-15       Impact factor: 25.391

9.  Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs.

Authors:  J B Jackson; S Y Kwok; J S Hopsicker; K J Sannerud; J J Sninsky; J R Edson; H H Balfour
Journal:  Transfusion       Date:  1989 Mar-Apr       Impact factor: 3.157

10.  Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes.

Authors:  P Langlade-Demoyen; F Michel; A Hoffenbach; E Vilmer; G Dadaglio; F Garicia-Pons; C Mayaud; B Autran; S Wain-Hobson; F Plata
Journal:  J Immunol       Date:  1988-09-15       Impact factor: 5.422

View more
  49 in total

Review 1.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.

Authors:  G W Nelson; R Kaslow; D L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

4.  Higher macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels from CD8+ T cells are associated with asymptomatic HIV-1 infection.

Authors:  F Cocchi; A L DeVico; R Yarchoan; R Redfield; F Cleghorn; W A Blattner; A Garzino-Demo; S Colombini-Hatch; D Margolis; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

5.  Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Authors:  O O Yang; A C Tran; S A Kalams; R P Johnson; M R Roberts; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

6.  Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.

Authors:  H Cao; P Kanki; J L Sankalé; A Dieng-Sarr; G P Mazzara; S A Kalams; B Korber; S Mboup; B D Walker
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.

Authors:  R P Johnson; R L Glickman; J Q Yang; A Kaur; J T Dion; M J Mulligan; R C Desrosiers
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 8.  Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.

Authors:  Barbara L Shacklett
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

Review 9.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.

Authors:  D Bienzle; K S Macdonald; K F Copeland; J J Bwayo; F A Plummer; K L Rosenthal
Journal:  Can J Infect Dis       Date:  2000-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.